The US Food and Drug Administration is working to remediate hiring irregularities the US Office of Personnel Management found during a recent audit before the OPM revisits the agency in early 2020.
The FDA fears that if it fails to resolve the audit findings in time, the OPM might rescind the hiring authority that the Health and Human Services Department delegated to it in
The audit findings arrived in December 2018 as the agency was launching an effort to satisfy industry concerns about reviewer shortfalls by